Kim Steel

Kim Steel's work experience includes various roles in the pharmaceutical and healthcare industry. Kim worked as a Global Study Lead at BeiGene starting in March 2023. Prior to that, they served as a Member of the Board of Directors at Regencor Inc. from January 2023. Kim also worked as a Consultant at Medical Developments International (MDI) starting from August 2022. Earlier in 2021, they held positions such as Senior Clinical Operation Manager/Consultant at Invion Limited, Director of Clinical Operations at Novoviah Pharmaceuticals, and Clinical Operations/Consultant at Aligos Therapeutics. In 2021, they were also a Senior Clinical Operations Manager at Tetratherix. Kim has experience as a Managing Director at SAPRO Consulting Pty Limited since October 2020. Before that, they worked as a Consultant at Wintermute Biomedical Pty Ltd from August 2022 to May 2023. Their previous role was as a Senior Project Manager at Avance Clinical from February 2021 to February 2022.

Kim Steel's education history includes the following:

- In 2013, Kim obtained a Certified Associate in Project Management (CAPM - PMI) from the Project Management Institute.

- From 2012 to 2013, Kim pursued a Diploma in Clinical Science with Merit from Oxford College, specializing in Clinical Science.

- In 2006 to 2007, Kim earned a Diploma (Level 5) in Business & People Management from the Institute of Leadership & Management UK.

- From 2004 to 2005, Kim completed a Certificate program in Understanding Business Behaviour from the Open University.

- In 2002, Kim began studying Prosthetics & Orthotics at the University of Strathclyde, but deferred the degree.

- In 2016 to 2017, Kim obtained a Diploma in Interior Design from The Interior Design Institute.

- In 2020, Kim received a Regulatory Affairs Certificate (RAC) in Global Regulatory Affairs from the Regulatory Affairs Professional Society (RAPS).